Clinical trial · Observational
Diagnostic Comparison of PET-magnetic Resonance and PET-CT in Patients With Oncologic Diseases
Diagnostic Comparison and Workflow Evaluation of Whole Body PET-magnetic Resonance and PET-CT With and Without Contrast Media in Patients With Oncologic Diseases
NCT02316431CI-TRIAL-00025208WorkflowcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Diagnostic accuracy of PET/magnetic resonance and PET/CT will be compared concerning primary tumor, regional nodes, metastasis (TNM) staging and therapeutic influence. Workflow scenarios will be evaluated to create imaging protocols which are time efficient and diagnostically accurate.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasm Staging | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Number of patients with correct TNM staging defined with PET/magnetic resonance versus PET/CT
- timeFrame
- 12 month
Secondary outcomes (1)
- measure
- Number of minutes needed per PET/magnetic resonance protocol compared to PET/CT
- timeFrame
- 12 month
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Male and female patients from 18-90 years * Written informed consent * Patients with a proven or suspected oncological disease referred for a clinically -Indicated PET/CT with of without contrast media Exclusion Criteria: * Pregnant or breast feeding women * Non compliance of the patient to follow the study instructions (e.g. hearing problems, dementia) * Inclusion in another clinical trial 30 days prior to inclusion * Age \< 30years * Contraindication for MRI (cardiac pacemaker, certain metal implants, claustrophobia * Known allergies to contrast CT or MRI contrast media * Patients with an glomerular filtration rate of \< 60ml/min/1.73m2
References
Publications (1)
- DERIVEDSekine T, Delso G, Zeimpekis KG, de Galiza Barbosa F, Ter Voert EEGW, Huellner M, Veit-Haibach P. Reduction of 18F-FDG Dose in Clinical PET/MR Imaging by Using Silicon Photomultiplier Detectors. Radiology. 2018 Jan;286(1):249-259. doi: 10.1148/radiol.2017162305. Epub 2017 Sep 14. PMID 28914600